FES Antikörper
Kurzübersicht für FES Antikörper (ABIN498416)
Target
Alle FES Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- This antibody detects endogenous levels of Fes protein. (region surrounding Lys161)
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Mouse.
-
Aufreinigung
- Affinity chromatography
-
Reinheit
- > 95 % by SDS-PAGE
-
-
-
-
Applikationshinweise
-
Western Blot: 1/500 - 1/1000. Immunohistochemistry: 1/50 - 1/200.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1,0 mg/mL
-
Buffer
- Phosphate buffered saline (PBS), pH 7.2., 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- FES (Feline Sarcoma Oncogene (FES))
-
Andere Bezeichnung
- C-Fes
-
Hintergrund
- FES is a protooncogene that encodes a protein-tyrosine kinase distinct from c-Src, c-Abl and other nonreceptor tyrosine kinases. FES was originally identified as the cellular homolog of several transforming retroviral oncoproteins. FES plays a role in regulating cytoskeletal rearrangements and inside out signalling that accompany receptor ligand, cell matrix and cell-cell interaction. Genetic analysis using transgenic mouse model implicate FES in the regulation of inflammation and innate immunity. FES modulates the innate immune response of macrophages to LPS challenge, in part, by regulating the internalization and down-regulation of the TLR4 receptor complex.Synonyms: FES, FPS, Proto-oncogene c-Fps, Proto-oncogene tyrosine-protein kinase Fes/Fps
-
Molekulargewicht
- approx. 80 kDa
-
Gen-ID
- 2242
-
NCBI Accession
- NP_001996
-
UniProt
- P07332
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Signaling Events mediated by VEGFR1 and VEGFR2
Target
-